Stay updated on PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page.

Latest updates to the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page
- Check2 days agoChange DetectedThe page now includes a funding attribution for 2014 (U.S. NIH Grant/Contract) and shows an updated Revision: v3.6.6. The Plain Language Summary and the older Revision: v3.6.5 have been removed, resulting in a streamlined public-facing page.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, signaling a minor update to the page. There are no specific content changes described in the provided data.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page's revision tag changed from Revision: v3.6.3 to Revision: v3.6.4, indicating a small update to the backend or content. This does not alter the study details or results.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing v3.6.2. This is a maintenance/version update that does not modify the substantive study information.SummaryDifference0.1%

- Check66 days agoChange DetectedA Plain Language Summary was added to the Study Details page to provide an accessible overview of the trial. The revision tag was updated to v3.6.2, reflecting the latest page update.SummaryDifference0.3%

- Check81 days agoChange DetectedAdded a 'No longer looking for participants' notice to indicate the study is not recruiting. Also added guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated the page revision to v3.6.0, while standardizing the Intervention header.SummaryDifference0.4%

Stay in the know with updates to PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page.